INTRODUCTION
============

Baculoviruses are wildly used for expression of recombinant proteins and and for biological pesticides. The family *Baculoviridae* is a large and diverse family of occluded viruses with double-stranded DNA genomes. *Baculoviridae* is divided into two genera based on occlusion body morphology. The nucleopolyhedroviruses (NPVs) produce large occlusion bodies containing multi- or single rod-shaped enveloped virions, named MNPV or SNPV in the nuclei of infected cells [@B001]. The other genera, the granuloviruses (GVs), produce small granular occlusion bodies that normally contain a single virion and are only found in *Lepidoptera* [@B002]. NPVs are further subdivided into two distinct groups (Group I and Group II) based on molecular phylogenies and whether contain a gp64 homologue or not. NPVs in group I show close relation compared to those of Group II [@B003].

So far, most researches focus on the AcMNPV because of easier manipulation, growth in cell culture and common sets of genes responsible for similar life cycles in all baculoviruses [@B004]. With the availability of the genomes of baculoviruses, more and more novel genes absent in AcMNPV have been reported, such as *p13* [@B005], *ld130* family [@B006] and *p49* [@B007] genes. Understanding the functions of these emerging genes will greatly promote the development of baculoviruses molecular biology and biopesticides.

*p13* gene was firstly discovered in *Leucania separata multinuclear* polyhedrosis virus (LsMNPV) from our laboratory in 1995 [@B005]. The Ls-*p13* ORF is 861 bp and encodes a 31 kDa leucine zipper-like protein (GenBank: AY394490). About nineteen baculoviruses containing *p13* homologues genes have been reported [@B008]-[@B017]. *p13* is predicted as an early and late gene and encodes a glycosyltransferase of family 8 [@B010]. However, the exact function of P13 protein is unclear.

The work reported focuses on the function of *p13*, including its expression profile，promoter activity, cellular localization and killing activity. We choose Ha-*p13* from *Heliothis armigera* single nucleocapsid nucleopolyhedrovirus (HaSNPV) and Ls-*p13* from LsMNPV to study the killing activity in homologous and heterologous system, respectively.

RESULTS
=======

Phylogenic analysis of P13 proteins
-----------------------------------

The complete amino acids sequences of *p13* genes from eleven baculoviruses were alignment by Pair Distances of ClustalW (Slow/Accurate). All the P13 proteins share the homology of amino acids from 41.4% to 56.9% [@B018]. They are clearly divided into two groups in phylogeny, that is *p13* genes of GVs and *p13* genes of Group II NPVs. *p13* genes of GVs are closely related while those of Group II NPVs appear to be more divergent (supplementary material).

The Ha-p13 gene was an early and late transcription gene
--------------------------------------------------------

The *p13* promoter contains the core sequences for early (CAT/AT) and late expression (TTAAG) elements ([Fig. 1](#F0001){ref-type="fig"}A) and an hr enhancer is widely located in upstream of *p13* promoter [@B019]. To confirm the prediction with experiment, Ha-*p13* promoter with or without the hr4 enhancer were inserted into pGL3-Basic reporter vectors, respectively. Luciferase assay indicate that Ha-*p13* promoter has activity from early 2 h p.i. to very late 90 h.p.i ([Fig. 1](#F0001){ref-type="fig"}B). Activity of Ha-*p13* promoter was low both in host Hz-AM1 cells ([Fig. 1](#F0001){ref-type="fig"}B, open triangle) and in heterologous Sf9 cells ([Fig. 1](#F0001){ref-type="fig"}B, filled triangle). However, when the hr4 enhancer was present upstream, the activity of Ha-*p13* promoter increased more than twenty times in host Hz-AM1 cells ([Fig. 1](#F0001){ref-type="fig"}B, filled square) and more than two thousand times in heterologous Sf9 cells ([Fig. 1](#F0001){ref-type="fig"}B, open square). The dramatic variety in the two types of cells might be the effect of some viral or cellular transcript factors act on hr4 enhancer.

![Structure and promoter activity of *p13* gene. (A) *p13* gene 5'UTR and putative encoded protein structures. (B) Luciferase activity assay of Ha-*p13* promoter and hr4 enhancer/Ha-*p13* promoter. Hz-AM1 Cells (open triangle) and Sf9 cells (filled triangle) were transfected with plasmid pGL3-Ha-*p13* promoter. In another experiment, Hz-AM1 Cells (filled square) and Sf9 cells (open square) were transfected with plasmid pGL3-hr4/Ha-*p13* promoter. (C) Western blot analysis. Hz-AM1 cells were infected with HaSNPV-G and lysates were prepared at 8, 18, 28, 38, 48, 60, 72, 90 h p.i. Ha-P13 expression was determined by Western blot using Ha-P13 polyclonal antiserum (upper panel). Actin was used as a control (lower panel). All the results were collected from triplicate experiments.](BMB-45-730-g0001){#F0001}

![Intracellular location of P13 in host and heterologous cells. (A) Ha-P13 location in host Hz-AM1 cells 48h after infection with HaSNPV-G. (B) Ls-P13 location in heterologous Sf9 cells 48 h after infection with rAc-hr5/IE1-Lsp13-G. Green fluorescence indicates the presence of either HaSNPV-G (A-1) or rAc-hr5/IE1-Lsp13-G (B-1) infection. The red fluorescence is the result of Red-labeled goat anti-rabbit antiserum after treatment with polyclonal antibodies against Ha-P13 (A-2) or Ls-P13 (B-2), which represents Ha-P13 or Ls-P13 exclusive localization.](BMB-45-730-g0002){#F0002}

On the other hand, the Hz-AM1 cells were harvested at different time after HaSNPV-G infection at 0.1 MOI. The cell extracts were subjected to SDS-PAGE followed by Western blot analysis with anti-HaP13 serum ([Fig. 1](#F0001){ref-type="fig"}C). The expression of Ha-P13 was observed from 8 h.p.i to 90 h.p.i, and reached its maximum at 28 h.p.i, then decreased gradually until 90 h.p.i. The results suggest that Ha-*p13* expression was an early and late transcription gene and expression consistently during virus infection.

Both Ha-P13 and Ls-P13 proteins are mainly located in cytoplasm membrane at very late stage
-------------------------------------------------------------------------------------------

To identify the subcellular localization of P13 proteins, the Hz-AM1 cells infected with HaSNPV-G and the Sf9 cells infected with rAc-hr5/IE1-Lsp13-G were fixed at 48 h p.i., respectively. The cells were then stained with anti-HaP13 or anti-LsP13 primary antibody and Texas Red-labeled secondary antibodies. Since the green fluorescence could observed in the whole cell infected with HaSNPV-G ([Fig. 2](#F0002){ref-type="fig"}A-1) or rAc-hr5/IE1-Lsp13-G ([Fig. 2](#F0002){ref-type="fig"}B-1), it was used as a marker of two kinds of recombinant baculoviruses infection. Laser confocal microscopic analysis, at the settings for eGFP or Texas Red, revealed the expression of Ha-P13 ([Fig. 2](#F0002){ref-type="fig"}A-2) or Ls-P13 ([Fig. 2](#F0002){ref-type="fig"}B-2) in the virus infected cells ([Fig. 2](#F0002){ref-type="fig"}A-1 and B-1), and the P13 localized exclusively to the cytoplasm membrane both in host Hz-AM1 cells ([Fig. 2](#F0002){ref-type="fig"}A-3) or heterologous systems sf9 cells ([Fig. 2](#F0002){ref-type="fig"}B-3).

![Identification of the killing activity of Ha-P13 in bioassay using dsRNA-Hap13. (A) Western blot detection of the Ha-*p13* knockdown by dsRNA-Hap13. 1, mock Hz-AM1 cells. 2, Hz-AM1 cells transfected with 5 μg dsRNA-Hap13 prior to infection with HaSNPV-G. 3, Hz-AM1 cells transfected with HaSNPV-G alone. (B) Identification of the killing activity of Ha-P13 in bioassay using dsRNA-Hap13. X axis, different groups in bioassay. Y axis, the mortality of larvae after 5 days. The results were triplicated.](BMB-45-730-g0003){#F0003}

p13 is a killing-associated gene in nature host system
------------------------------------------------------

In order to investigate the interference efficacy of dsRNA to Ha-*p13*, dsRNA-Hap13 was transfected Hz-AM1 cells prior to infection with HaSNPV-G. A dose of 5 μg dsRNA-Hap13 was transfected prior to HaSNPV-G infection could down-regulated most of Ha-P13 expression ([Fig. 3](#F0003){ref-type="fig"}A, lane 2).

To investigate the function of Ha-P13 in HaSNPV-G infection, five groups of insect bioassays were performed (N = 50). Co-injected with dsRNA-Hap13 and HaSNPV-G, the larvae mortality decreased with the increase of dsRNA-Hap13 concentration ([Fig. 3](#F0003){ref-type="fig"}B). When 5 μg of dsRNA-Hap13 were co-injected, the larvae mortality was decreased from 70% ([Fig. 3](#F0003){ref-type="fig"}B, only HaSNPV-G injection) to 10% ([Fig. 3](#F0003){ref-type="fig"}B, HaSNPV-G ＋ 5 μg dsRNA-Hap13 co-injection). Few of *H. armigera* were dead when 5 μg of dsRNA-Hap13 was injected solely ([Fig. 3](#F0003){ref-type="fig"}B, 5 μg dsRNA-Hap13 injection) suggesting that dsRNA-Hap13 itself was not toxic to the host.

![Bioassay of Ls-P13 function in *S. exigua* larvae. (A) The structures of recombinant rAc-G and rAc-hr5/IE1-Lsp13-G. (B) Sf9 cells infected with two recombinant baculoviruses. 1, mock cells; 2, 3, Observation of rAc-G and rAc-hr5/IE1-Lsp13-G production with fluorescence microscopy. (C) Western blot assay of Ls-P13 expression in Sf9 cells. In the lane of purified Ls-P13, MBP tag of MBP-LsP13 fusion protein had been cleaved by Factor Xa. (D) Bioassay of Ls-P13 function in *S. exigua* larvae. 1 (group I), larvae of *S. exigua* were injected with rAc-G (filled square), rAchr5/IE1-Lsp13-G (filled triangle) and Grace's medium (open diamond), respectively. 2 (group II), larvae of *S. exigua* were injected with mixtures of rAc-G and Ls-P13 protein (filled square), rAc-G (filled triangle), Grace's medium (broken line), Ls-P13 protein (decussation), respectively. X axis, different groups in bioassay. Y axis, the mortality of larvae in different days. The results were triplicated.](BMB-45-730-g0004){#F0004}

AcMNPV p35 (*Ac-p35*) gene is an apoptosis suppressor gene, which is neither present in HaSNPV-G nor in H. armigera genome. When 5 μg dsRNA-Acp35 was co-injected with HaSNPV-G, the mortality was nearly no much reduced compared with HaSNPV-G sole injection ([Fig. 3](#F0003){ref-type="fig"}B, HaSNPV ＋ 5 μg dsRNA-Acp35 co-injection vs HaSNPV injection), which eliminated the possibility that dsRNA triggered innate immunity and served to reduce mortality in insects. From above results, we concluded that *p13* gene is a killing-associated gene in its natural host.

p13 is also a killing-associated gene in heterologous system
------------------------------------------------------------

Two experimental groups were designed to investigate the effect of Ls-P13 on rAcMNPVs infection in larvae of *S. exigua*. The infection of two recombinant baculoviruses, rAc-G and rAc-hr5/IE1-Lsp13-G ([Fig. 4](#F0004){ref-type="fig"}A) used in bioassay were confirmed by fluorescence microscopic ([Fig. 4](#F0004){ref-type="fig"}B) and Western blot analysis ([Fig. 4](#F0004){ref-type="fig"}C). In group I ([Fig. 4](#F0004){ref-type="fig"}D, group I), the mortality of both rAc-hr5/IE1-Lsp13-G and rAc-G reached 100% after five days, but the mortality of rAc-hr5/IE1-Lsp13-G was significantly higher in the early phase.

In group II ([Fig. 4](#F0004){ref-type="fig"}D, group II), nearly all of the larvae of *S. exigua* survived when injected with grace's medium or Ls-P13 protein. The result demonstrated that Ls-P13 protein itself was not toxic to *S. exigua*. Compared with rAc-G infection, the co-injection of the protein Ls-P13 with rAc-G markedly accelerated the killing process.From above results, we concluded that Ls-P13 could accelerate the killing process of rAcMNPVs no matter it was expressed *in vivo* or co-injected with rAc-G.

DISCUSSION
==========

The *p13* gene of LsMNPV was first reported in 1995 [@B005]. However, the *p13* function was has been neglected for many years. Our attention was focused on gene *p13* again based on three main reasons. The first is that nearly twenty *p13* genes have been identified in recent years and share no homology with any other gene. The second is that all the reported *p13* genes are present specifically in Group II NPVs and some GVs, but not Group I NPVs. Therefore, *p13* can be proposed as a second marker, besides gp64 gene, for differentiating between the two NPV groups in molecular phylogeny [@B020]. The most important reason, however, is that *p13* contains a complex promoter [@B021], unique motifs, and also encodes a putative glycosyltranferase of family 8 which reported so far in mammals, yeasts and bacteria but not in viruses [@B022].

*p13* gene contains a GTGTTATA box, a CAT/AT box for the early promoter and a TTAAG box for the late promoter in its 5'-UTR, a mini cistron following the core sequence of the early promoter, and an enhancer hr (n) (n is different among Group II NPVs) at its 5'-UTR for early high-expression [@B019]. Our work confirmed that *p13* expression was regulated by early and late promoter. Interestingly, we also found that the hr4 enhancer/Ha-*p13* promoter not only has no host specificity, but also increases nearly 100 times activity in heterogeneous Sf9 cells compared with that in homologous Hz-AM1 cells. We presume there are some viral or cellular factors to regulate *P13* normal low-expression in nature host cells.

Introduction of dsRNA into a wide variety of cells and organisms results in post-transcriptional depletion of the homologue endogenous mRNA [@B023]. Our results showed that dsRNA-Hap13 could specifically knockdown Ha-P13 expression in nature host Hz-AM1 cells. Co-injection dsRNA-Hap13 with HaSNPV-G could decrease the toxicity of HaSNPV-G and the efficacy was dsRNA-Hap13 dose dependent.

On the other hand, as *p13* gene was absent in group I NPVs such as baculovirus AcMNPV, we inserted Ls-*p13* gene into AcMNPV to evaluate whether foreign *p13* gene in heterologous system was also killing-associated. Our results clearly indicated that Ls-P13 could accelerate the killing rate of AcMNPV. Although the mechanism of P13 as a killing-associated gene is unknown, its killing property is attractive and promotes us to further study P13 functions and its potential applications in biopesticides.

MATERIALS AND METHODS
=====================

Cells, insects and viruses
--------------------------

*Heliothis zea* (Hz-AM1) cells and *Spodoptera frugiperda* pupal ovarian cell line (Sf9) cells were cultured at 27℃ in Grace's medium (Gibco/BRL), supplemented with 10% fetal bovine serum (Gibco/BRL). Larvae of *S. exigua* and *H. armigera* were feed with artificial diet and maintained as previously described [@B024]. Baculoviruses HaSNPV with eGFP droved by polyhedron promoter (HaSNPV-G) and wt-LsMNPV were kindly donated by Dr. Zhihong Hu and Dr. Shengliang Chen (Wuhan Institute of Virology, Chinese Academic of Sciences).

Phylogenetic analysis
---------------------

The GenBank accession numbers used for alignments are as follows: for *p13* genes, AY394490 (LsMNPV), AF303045 (HaSNPV), NC 004690 (AhNPV), AF547984 (AoGV), NC 007151 (CcNPV), NC 005068 (ClGV), U53466 (CpGV), AY126275 (McNPV), AF499596 (PoGV), AF169823 (SeNPV), AF325155 (SlNPV). All the reported *p13* sequences translations were aligned by using the ClustalW algorithm. Genetic distances were estimated by the Kimura two-parameter matrix and phylogenetic tree was generated by MegAlign method of DNAStar software.

Plasmids
--------

Plasmid pMal-p2 was obtained from New England Biolabs, United Kingdom. Plasmid pFastBac1 was obtained from Invitrogen. Plasmid pIEHR3 containing hr5 enhancer and IE1 promoter fusion sequence was kindly donated by Jarvis *et al*. [@B020]. Luciferase reporter plasmid pGL3-hr4/Hap13promoter was constructed by inserting the PCR-amplified 5\' non-coding region of Ha-p13 gene (including hr4 enhancer and Ha-p13 promoter fusion sequence) from HaSNPV into the *Bgl*II and *Hind*III sites of plasmid sites of the pGL3-Basic vector (Promega). For unique hap13 promoter activity assay, −1 to −175 promoter regions were amplified from pGL3-hr4/Hap13 was inserted into *Sac*I and *Sma*I sites of pGL3-Basic vector to generate the reporter plasmid pGL3-Phap13.

Recombinant baculoviruses construction
--------------------------------------

AcBac-to-Bac-eGFP expression system [@B025] was used to construct recombinant AcMNPVs to investigate Ls-P13 function in heterologous Sf9 cells. Briefly, the foreign gene was inserted into pFastBac1 donor plasmids and transformed into *E. coli* DH10Bac containing AcBacmid-eGFP with helper plasmid. After white/blue selection on kanamycin/gentamicin/tetracycline plates and PCR screening, the resulting Bacmids were transfected into Sf9 cells to yield the rAcMNPVs.

Protein expression, purification and antibody production
--------------------------------------------------------

Ls-*p13*, and Ha-*p13* were cloned into the bacterial expression plasmid pMal-p2 for expression. The foreign genes were fused with the MalE (maltose binding protein \[MBP\]) gene of *E.coli* at the N-terminus, and the expressed fusion proteins MBP/Ls-P13 and MBP/Ha-P13 were purified by affinity chromatography taking advantage of the affinity of MBP for maltose. Finally, the purified fusion proteins were used to inoculate animals for polyclonal antibody preparation.

Luciferase activity and Western blot
------------------------------------

Hz-AM1 cells were seeded into 24-well plates at about 60% confluency and maintained at 27℃. Transfection was performed with 0.8 μg expression plasmid and reporter plasmid using Cellfectin reagent according to the manufacturer's protocol (Invitrogen). The cells were harvested at different stages after transfection, and the luciferase activity was measured with Luciferase Reporter Assay System (Promega) along with the manufacturer's protocol. On the other hand, the non-transfected Hz-AM1 cells in the other wells were infected with HaSNPV-G at 0.1 MOI. The infected cells were lysed at different stages and Ha-P13 expression profile was evaluated by Western blot. Data were collected from the average of triplicated assays of transfections.

Immunofluorescence confocal microscopy
--------------------------------------

Following infection with HaSNPV-G or rAc-hr5/IE1-Lsp13-G in 48 h, the Hz-AM1 cells or Sf9 cells were fixed in 4% paraformaldehyde in PBS for 20 min at room temperature, permeabilized with 0.5% Triton X-100 in PBS for 10 min, followed by 30 min incubation in the presence of 1% BSA. The cells were then incubated with rabbit polyclonal antibodies against P13 (1：100). Following three PBS washes, the cells were incubated in PBS containing Texas Red-labeled goat anti-rabbit antibodies (1：50 dilution in PBS, ZhongShan Biotech Co., China) for 1h. After several washes, the cells were observed under a Leica TCS SP1 laser confocal microscopy.

RNAi procedure
--------------

Double-stranded RNA (dsRNA) was synthesized *in vitro* using the ScriptMAX^TM^ Thermo T7 Transcription Kit (Toyobo) following the manufacturer's instructions. Briefly, the 740 nucleotides fragment (from 21 to 761) of Ha-*p13* ORF (831 nt) with an ATG codon, was amplified by PCR from the constructed expression vector pMal-p2-Hap13. The primers were flanked forward and reverse T7 promoter sites. The PCR product was used for the *in vitro* transcription to obtain the dsRNA, using the T7 polymerase according to the provided protocol.

5 μg of dsRNA-Hap13 was transfected prior to infection with HaSNPV-G in Hz-AM1 cells. The interference efficacy of dsRNA-Hap13 was detected by Western blot. On the other hand, different amounts of dsRNA-Hap13 were co-injected in the hemolymph of third instar *H. armigera* larvae with HaSNPV-G to study the effect of P13 on viral infection and dsRNA-Hap13 unique injection as control. To identify whether dsRNA triggered innate immune response and to reduce mortality in insects, other dsRNA targeting p35 gene of AcMNPV was used as control. HaSNPV-G (1 × 10^6^) was injected with 10 μl in all groups. Dead insects were investigated for GFP fluorescence and all results were triplicate.

Bioassay
--------

Two experiment groups of were performed to study Ls-P13 effect on AcMNPV infection. In group 1, equivalent titer (1 × 10^6^) and volume (10 μl) of rAc-G and rAc-hr5/IE1-Hsp13-G were directly injected into the hemolymph of third instar larvae of *S. exigua* and Grace's medium as a control. In group 2, the purified MBP/Ls-P13 protein was used to co-inject third instar larvae with rAc-G and rAc-G injection was used as control. Dead insects were counted from the third day and the experiments were triplicate.
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